18.222.148.124
dgid:
enl:
npi:0

-Advertisement-

-Advertisement-

Home Removing barriers of MGD care: The TearCare Fair Access Campaign Part 1

Dry Eye

Removing barriers of MGD care: The TearCare Fair Access Campaign Part 1

Read More

By rd360stg

Varenicline nasal spray improves dry eye symptoms in wide range of patients

By rd360stg

Dry eye disease signs significantly more severe with increasing age

By rd360stg

Tips for prescribing and monitoring patients on Flarex

By rd360stg

Hyaluronic Acid and Trehalose: New Combination for Treating Dry Eye Disease

-Advertisement-

-Advertisement-

-Advertisement-

By rd360stg

Acupuncture for dry eye disease management?

By rd360stg

Single thermal pulsation system treatment appears effective for MGD

By rd360stg

OC-01 nasal spray appears effective in improving signs, symptoms of dry eye disease

By rd360stg

Intense Pulsed Light plus meibomian gland expression effective in MGD-DED

-Advertisement-

-Advertisement-

-Advertisement-

By rd360stg

Single TearCare treatment significantly improves DED symptoms

By rd360stg

Poor correlation found between symptoms and signs in patients with MGD

By rd360stg

Diabetes-related dry eye disease highlighted at conference

By rd360stg

Proxymetacaine response may help differentiate between DED, ocular neuropathic pain

-Advertisement-

-Advertisement-

Videos

Removing barriers of MGD care: The TearCare Fair Access Campaign Part 1

19 Oct, 2022

Tips for prescribing and monitoring patients on Flarex

29 Sep, 2022

-Advertisement-

-Advertisement-

Contact Info

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899

[email protected]

Social Links

© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved

-Advertisement-

-Advertisement-